blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0854870

EP0854870 - SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.04.2010
Database last updated on 30.10.2024
Most recent event   Tooltip17.06.2011Lapse of the patent in a contracting state
New state(s): CH, GB, GR, IE, IT, LI, LU
published on 20.07.2011  [2011/29]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2010/10]
Former [2009/24]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
Former [1998/31]For all designated states
MERCK & CO., INC.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
Inventor(s)01 / SELNICK, Harold, G.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / CLAREMON, David, A.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / LIVERTON, Nigel, J.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[1998/31]
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2006/49]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2004/27]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Former [1998/31]Thompson, John Dr.
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date96937654.002.10.1996
[1998/31]
WO1996US15880
Priority number, dateUS19950005059P06.10.1995         Original published format: US 5059 P
US19950005063P06.10.1995         Original published format: US 5063 P
GB1996000297513.02.1996         Original published format: GB 9602975
GB1996000290713.02.1996         Original published format: GB 9602907
[1998/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9712876
Date:10.04.1997
Language:EN
[1997/16]
Type: A1 Application with search report 
No.:EP0854870
Date:29.07.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 10.04.1997 takes the place of the publication of the European patent application.
[1998/31]
Type: B1 Patent specification 
No.:EP0854870
Date:10.06.2009
Language:EN
[2009/24]
Search report(s)International search report - published on:US10.04.1997
(Supplementary) European search report - dispatched on:EP25.11.1998
ClassificationIPC:C07D401/14, A61K31/415, A61K31/44, A61K31/445, C07D417/14
[1999/02]
CPC:
C07D401/14 (EP,KR); A61P17/00 (EP); A61P19/00 (EP);
A61P19/10 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P43/00 (EP); A61P7/00 (EP);
C07D417/14 (EP); Y02P20/55 (EP) (-)
Former IPC [1998/31]C07D233/76, C07D233/86, C07D233/88
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1998/31]
TitleGerman:SUBSTITUIERTE IMIDAZOLE MIT KREBSREMMENDER UND CYTOKININHIBIERENDER WIRKUNG[1998/31]
English:SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY[1998/31]
French:IMIDAZOLES SUBSTITUES AYANT UNE ACTIVITE ANTICANCEREUSE ET INHIBITRICE DE CYTOKINE[1998/31]
Entry into regional phase06.05.1998National basic fee paid 
06.05.1998Search fee paid 
06.05.1998Designation fee(s) paid 
06.05.1998Examination fee paid 
Examination procedure24.04.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
06.05.1998Examination requested  [1998/31]
26.08.2003Despatch of a communication from the examining division (Time limit: M06)
26.02.2004Reply to a communication from the examining division
04.05.2005Despatch of a communication from the examining division (Time limit: M04)
27.07.2005Reply to a communication from the examining division
28.11.2008Communication of intention to grant the patent
27.03.2009Fee for grant paid
27.03.2009Fee for publishing/printing paid
Opposition(s)11.03.2010No opposition filed within time limit [2010/20]
Fees paidRenewal fee
02.11.1998Renewal fee patent year 03
02.11.1999Renewal fee patent year 04
31.10.2000Renewal fee patent year 05
31.10.2001Renewal fee patent year 06
07.10.2002Renewal fee patent year 07
06.10.2003Renewal fee patent year 08
06.10.2004Renewal fee patent year 09
07.10.2005Renewal fee patent year 10
05.10.2006Renewal fee patent year 11
15.10.2007Renewal fee patent year 12
27.03.2008Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT10.06.2009
BE10.06.2009
DK10.06.2009
FI10.06.2009
IT10.06.2009
NL10.06.2009
SE10.09.2009
GR11.09.2009
ES21.09.2009
GB02.10.2009
IE02.10.2009
LU02.10.2009
PT10.10.2009
CH31.10.2009
LI31.10.2009
FR02.11.2009
[2011/25]
Former [2010/44]AT10.06.2009
BE10.06.2009
DK10.06.2009
FI10.06.2009
NL10.06.2009
SE10.09.2009
ES21.09.2009
PT10.10.2009
FR02.11.2009
Former [2010/28]AT10.06.2009
BE10.06.2009
DK10.06.2009
FI10.06.2009
NL10.06.2009
SE10.09.2009
ES21.09.2009
PT10.10.2009
Former [2010/19]AT10.06.2009
BE10.06.2009
FI10.06.2009
NL10.06.2009
SE10.09.2009
ES21.09.2009
PT10.10.2009
Former [2010/05]AT10.06.2009
FI10.06.2009
NL10.06.2009
SE10.09.2009
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[X]WO9314081  (SMITHKLINE BEECHAM CORP [US]);
 [X]WO9503297  (SMITHKLINE BEECHAM CORP [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.